You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,238,640


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,238,640
Title:Pharmaceutical suspension composition
Abstract: An aqueous oral liquid pharmaceutical composition system with reduced propensity for agglomeration and phase separation which is particularly amendable to the suspension of one or more pharmaceutical actives that are substantially insoluble in water. The oral liquid pharmaceutical composition may further comprise pharmaceutical actives that are soluble in water and dissolve in the aqueous medium. In the composition of the invention both suspended and any dissolved active agents are distributed homogeneously.
Inventor(s): Dickerson; Jay (Midlothian, VA), Mark; William (Glen Allen, VA), Trimmer; Annabelle (Manakin-Sabot, VA), Jaeger; David (Chester, VA), Alley; Amanda (Midlothian, VA)
Assignee: Wyeth LLC (New York, NY)
Application Number:15/349,101
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

United States Patent 10,238,640: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,238,640, titled "Pharmaceutical suspension composition," is a significant patent in the pharmaceutical industry, particularly in the realm of suspension formulations. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

Publication Number and Authority

The patent in question is US10238640B2, issued by the United States Patent and Trademark Office (USPTO)[2].

Prior Art and Background

The patent builds upon prior art, including U.S. Pat. Nos. 5,272,137 and 5,409,907, which describe liquid suspension systems for substantially water-soluble pharmaceutical actives. The current patent improves upon these earlier inventions by providing a more stable and effective suspension composition[2].

Composition and Ingredients

The pharmaceutical suspension composition covered by this patent includes ingredients such as ibuprofen, glycerol, xanthan gum, microcrystalline cellulose, and other components like sorbitol and acetic acid. These ingredients are carefully formulated to ensure the stability and efficacy of the suspension[2].

Scope of the Patent

Claims

The patent includes several claims that define the scope of the invention. These claims are critical in determining what aspects of the pharmaceutical suspension composition are protected. Key claims include:

  • The composition of the suspension, including the specific ratios and types of ingredients.
  • The method of preparing the suspension.
  • The use of the suspension for treating various conditions, such as pain and inflammation[2].

Protection and Exclusivity

The patent grants the exclusive right to make, use, or sell the described pharmaceutical suspension composition. This exclusivity is a cornerstone of the patent system, allowing inventors to reap the benefits of their innovation while preventing others from using the same invention without permission[4].

Patent Claims and Structure

Claim Types

The patent includes various types of claims, such as independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Analysis

The claims in this patent are detailed and specific, ensuring that the protection is narrowly tailored to the invention. For example, Claim 1 might describe the overall composition, while subsequent claims might detail specific ratios of ingredients or methods of preparation. This structure helps in defining the boundaries of the invention and what would constitute infringement[2].

Patent Landscape

International Patent Family

The patent has nine patent family members, indicating that similar patents have been filed in other jurisdictions to protect the invention globally. This is a common strategy to ensure broad protection across different markets[5].

Related Patents and Prior Art

The patent landscape includes other related patents and prior art that have contributed to the development of pharmaceutical suspension compositions. Understanding this landscape is crucial for identifying potential infringement risks and opportunities for further innovation[1][4].

Global Dossier and International Search

Tools like the Global Dossier and international patent databases (e.g., EPO's esp@cenet, JPO's database, and WIPO's PATENTSCOPE) are essential for searching and analyzing the global patent family and related patents. These resources help in identifying office actions, citations, and other relevant data across different jurisdictions[1].

Economic and Technological Trends

Patent Activity in the Pharmaceutical Sector

The pharmaceutical sector is highly active in terms of patent filings. According to USPTO data, the number of patents granted in this sector reflects the ongoing innovation and competition. For instance, in 2018, the USPTO awarded a significant number of utility patents, with a substantial portion going to the pharmaceutical and biotechnology fields[4].

Technological Fields and Classification

Patents in the pharmaceutical sector are classified under specific technological fields, such as chemistry and pharmacology. The World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields, is used to categorize these patents. This classification helps in tracking trends and innovations within specific areas[4].

Practical Implications

Licensing and Collaboration

The exclusive rights granted by this patent can be leveraged through licensing agreements or collaborations. Companies may choose to license the technology to other firms or collaborate on further research and development to expand the market reach of the pharmaceutical suspension composition[4].

Litigation and Enforcement

Understanding the scope and claims of this patent is crucial for avoiding potential litigation. Companies must ensure that their products do not infringe on the protected claims, and any disputes can be resolved through legal means[4].

Key Takeaways

  • Patent Scope and Claims: The patent protects a specific pharmaceutical suspension composition, including its ingredients and method of preparation.
  • International Protection: The patent has a global family with nine members, ensuring broad protection.
  • Economic and Technological Trends: The pharmaceutical sector is highly active in patent filings, with significant innovations in suspension formulations.
  • Practical Implications: The patent can be leveraged through licensing and collaboration, and its scope must be carefully considered to avoid litigation.

FAQs

What is the main subject of United States Patent 10,238,640?

The main subject is a pharmaceutical suspension composition, particularly for formulations containing ibuprofen.

How does this patent build upon prior art?

It improves upon earlier liquid suspension systems by providing a more stable and effective composition.

What are the key ingredients in the patented composition?

Key ingredients include ibuprofen, glycerol, xanthan gum, microcrystalline cellulose, sorbitol, and acetic acid.

How can companies protect themselves from infringing on this patent?

Companies must ensure their products do not match the protected claims and consider licensing agreements or collaborations.

What tools can be used to search for related patents globally?

Tools like the Global Dossier, EPO's esp@cenet, JPO's database, and WIPO's PATENTSCOPE can be used to search for related patents globally.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Google Patents - US10238640B2: https://patents.google.com/patent/US10238640B2/en
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NSF - Invention: U.S. and Comparative Global Trends: https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. DrugPatentWatch - Patent 10,238,640: https://www.drugpatentwatch.com/p/patent/10238640

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,238,640

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Haleon Us Holdings CHILDREN'S ADVIL ALLERGY SINUS chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021587-001 Feb 24, 2004 OTC Yes Yes 10,238,640 ⤷  Subscribe Y ⤷  Subscribe
Haleon Us Holdings CHILDREN'S ADVIL-FLAVORED ibuprofen SUSPENSION;ORAL 020589-002 Nov 7, 1997 OTC No No 10,238,640 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,238,640

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2567075 ⤷  Subscribe
China 1988893 ⤷  Subscribe
European Patent Office 1748765 ⤷  Subscribe
European Patent Office 2465497 ⤷  Subscribe
Mexico PA06013481 ⤷  Subscribe
Turkey 200501948 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.